Sort
30,917 grants matching “tumor microenvironment”
Protein Kinase Cz targets in Intestinal Cancer Stem Cells
$445,518Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA
Protein Kinase Cz targets in Intestinal Cancer Stem Cells
$445,518Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
Modulation of Pigment Epithelium-Derived Factor's activities as potential therape
$445,500Stephanie Filleur · Texas Tech University Health Scis Center · R15 · FY2012 · CA
Role of Th2 cytokines in progenitor-mediated formation of tumor lymphatics
$445,500Sophia Ran · Southern Illinois University Sch Of Med · R15 · FY2024 · CA
Induction of Tumor Immunity by Secreted HSP-gp96
$445,429Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2008 · CA
The role of P16Ink4a in adult skeletal muscle stem cells
$445,344Brian Feeley · University Of California, San Francisco · R01 · FY2023 · AR
Targeting Metabolic Crosstalk in Pancreatic Cancer
$445,319Christopher J. Halbrook · University Of California-Irvine · R37 · FY2025 · CA
MALIGNANT PROGRESSION IN PAPILLOMAVIRUS TRANSGENIC MICE
$445,270University Of California San Francisco · R01 · FY2000 · CA
Three-dimensional organoid models to study breast cancer progression
$445,227Shilpa Sant · University Of Pittsburgh At Pittsburgh · R37 · FY2018 · CA
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
$445,226Zhiguo Li · University Of Kentucky · R01 · FY2025 · CA
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
$445,226Zhiguo Li · University Of Kentucky · R01 · FY2022 · CA
Molecular Oncology Training Program
$445,219Gary K Schwartz · Columbia University Health Sciences · T32 · FY2021 · CA
Integrating cancer genomics and spatial architecture of tumor infiltrating lymphocytes
$445,177Hanlee Ji · Stanford University · R01 · FY2023 · CA
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$445,105Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2023 · AI
Dual targeting of XPO1 and BTK in B cell malignancies
$445,083Rosa Lapalombella · Ohio State University · R01 · FY2016 · CA
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
$445,054Manuel L Penichet · University Of California Los Angeles · R01 · FY2015 · CA
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2021 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2020 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2019 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2018 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2017 · OD
Project 2: Elucidating interactions between genetic and environmental drivers of prostate cancer patient outcomes
$444,977Matthew R Cooperberg · University Of California, San Francisco · U54 · FY2025 · CA
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$444,969Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
$444,969William J Aronson · University Of California Los Angeles · R01 · FY2018 · CA
Exosome secretion in breast cancer progression
$444,908Alissa M Weaver · Vanderbilt University · R01 · FY2023 · CA